Climate Change Data

Faes Farma, S.A.

Climate Impact & Sustainability Data (2021, 2023)

Reporting Period: 2021

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance and Ethics

Climate Goals & Targets

Supply Chain Management

Responsible Procurement
  • minimise the environmental impacts associated with their activities and, in particular, with the products they develop for Faes Farma

Climate-Related Risks & Opportunities

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:7,580 tCO2eq/year (Scope 1 and 2)
Scope 1 Emissions:4,965 tCO2e/year
Scope 2 Emissions:2,615 tCO2e/year
Scope 3 Emissions:Screening completed in 2023; detailed calculation in 2024
Renewable Energy Share:42% of electricity from renewable sources
Total Energy Consumption:25,550,380 kWh/year (electricity), 10,289,929 kWh/year (natural gas)
Water Consumption:166,471 m3/year
Waste Generated:1,389 tons/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environmental Management
  • Climate Change
  • Circular Economy
  • Sustainable Resource Use
  • Biodiversity Protection
  • Human Capital Management
  • Health and Safety
  • Social Relations
  • Equality, Diversity and Accessibility
  • Responsible Supply Chain
  • Corporate Governance
  • Ethics and Integrity
  • Patient and User Health

Environmental Achievements

  • Reduced water consumption by 12% in the last two years.
  • Increased waste recovery in Animal Health and Nutrition to 80% (from 58% in 2022).
  • Doubled Group’s production of electricity from renewable sources.
  • LEED Gold certification for new pharmaceutical plant in Derio (Biscay).
  • Study and definition of potential greenhouse gas emission reduction measures.

Social Achievements

  • Implemented teleworking in the Group.
  • Group’s pay gap is 6%.
  • Executive pay gap is -1%.
  • 96% of contracts are permanent.
  • Implemented Corporate Recruitment Policy and anti-harassment protocol.
  • Implemented Corporate Internal Communication Plan.
  • Donated over €91,000 to entities contributing to SDGs 1, 2, and 3.
  • Donated over 67,000 units of products to entities contributing to SDGs 2 and 3.
  • Training support to 61 trainees or interns.

Governance Achievements

  • 55% independent board members.
  • 44.4% women on the Board of Directors.
  • Board members received specific training in Sustainability and Cybersecurity.
  • New Internal Information System Policy and whistleblower channel implemented.
  • Annual evaluation of the Board of Directors, Committees and Chairman with favourable results.
  • ESG metrics accounted for 10% of total annual variable remuneration for the executive director.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Specific calculation of Scope 3 key sources in 2024.
  • Approval of corporate emissions reduction plan in 2024.
  • Registration of Group’s carbon footprint with MITECO in 2024.
  • ISO 14001 certification at the new Derio plant in 2024.

Environmental Challenges

  • Macroeconomic challenges: wars, extreme weather, cybersecurity risks, disinformation, rising living costs, supply chain disruptions.
  • Pharmaceutical sector challenges: proposed revision of European pharmaceutical legislation.
  • Pharmaceutical sector opportunities: upcoming Strategic Pharmaceutical Industry Plan.
  • Livestock sector challenges: demanding animal welfare standards, high production costs, lower animal production, emerging diseases.
  • Climate-related risks (detailed analysis in 2024).
Mitigation Strategies
  • Adaptation and management strategies for climate change, demographic changes, technological acceleration, and geopolitical power concentration.
  • Emissions reduction plan (started in 2023).
  • ESG Strategy with 36 measures to integrate sustainability into business and decision-making.
  • Risk Management System to identify, assess, prevent, monitor, and reduce significant financial and non-financial risks.
  • Actions to address supply chain disruptions (not specified).

Supply Chain Management

Supplier Audits: Number and percentage not explicitly stated; audits conducted on direct suppliers linked to product quality and safety.

Responsible Procurement
  • Updated Third Party Code of Ethics and Conduct, including anti-corruption clause in new contracts.

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
Transition Risks
  • Regulatory changes
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: GRI

Certifications: ISO 14001

Third-party Assurance: PricewaterhouseCoopers Auditores, S.L.

UN Sustainable Development Goals

  • SDG 2
  • SDG 3
  • SDG 4
  • SDG 6
  • SDG 7
  • SDG 8
  • SDG 9
  • SDG 12
  • SDG 13
  • SDG 16
  • SDG 17

Report details how various initiatives contribute to these goals.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Euskadi Sariak 2023 award